HOME >> MEDICINE >> NEWS
REVLIMID(R) granted approval by FDA for treatment of multiple myeloma

Summit, N.J., June 29 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced that the U.S. Food and Drug Administration (FDA) has granted approval for its Supplemental New Drug Application (sNDA) for an additional indication for REVLIMID (lenalidomide), for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy. REVLIMID is also approved for use in the treatment of patients with transfusion-dependent anemia due to Low-or- Intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Multiple myeloma is the second most common blood cancer in the United States, affecting approximately 50,000 people. About 14,600 new cases of multiple myeloma are diagnosed each year and about 12,000 Americans are expected to die of multiple myeloma in 2006. In the REVLIMID (lenalidomide)/dexamethasone treatment group, 151 patients (45%) underwent at least one dose interruption with or without a dose reduction of REVLIMID (lenalidomide) compared to 21% in the placebo/dexamethasone treatment group. Most adverse events and Grade 3 or 4 adverse events were more frequent in patients who received the combination of REVLIMID (lenalidomide)/dexamethasone compared to placebo /dexamethasone.

"The FDA approval of REVLIMID offers a new oral therapeutic option to this particular group of patients with multiple myeloma," said Graham Burton, M.D., SVP, Regulatory Affairs and Pharmacovigilance for Celgene. REVLIMID will be available in the following strengths: 5 mg, 10 mg, 15 mg, and 25 mg capsules.


'"/>

Contact: Brian P. Gill
bgill@celgene.com
908-673-9530
Weber Shandwick Worldwide
30-Jun-2006


Page: 1

Related medicine news :

1. Acrux granted first grant in Europe, triggering payment from Lilly
2. Four new us patents granted to Acrux for transdermal drug delivery
3. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
4. Sutent achieves first line EAU approval for kidney cancer
5. Breast cancer drug receives FDA approval
6. March of Dimes: Drug to prevent preterm birth needs prompt FDA approval
7. Worlds first approval of new HIV drug TMC114 provides potent new treatment option with FUZEON
8. Aussie of the Year wins approval for cervical cancer vaccine
9. UC Berkeley team helps win approval for life-saving drug for African women
10. Cincinnati Childrens applauds EU approval of rotavirus vaccine
11. TPV EU approval provides new HIV active drug to be combined with FUZEON

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... COPENHAGEN, Denmark (PRWEB) , ... October 11, 2018 ... ... Excellence Awards for 2018. The medalists are leading scientists in their fields recognized ... achievement in advancing science and technology relevant to the future of food, nutrition ...
(Date:10/6/2018)... OBISPO, Calif. (PRWEB) , ... October 06, 2018 , ... ... it seems every bone in their body is visible? San Luis Obispo nurse ... of stress, has more to do with the human primitive body response and little ...
(Date:10/5/2018)... Tenn. (PRWEB) , ... October 05, 2018 , ... ... providing comprehensive eye care, LASIK/PRK and cataract surgery to patients residing in middle ... outstanding Board Certified Ophthalmologists in the United States, Dr. Stewart Shofner ...
(Date:10/5/2018)... ... , ... Woman-owned company, FlagandBanner.com, will fly a pink version of the Arkansas ... breast cancer. The custom made flag was manufactured onsite in 2017. The trend of ... purchased a pink New Mexico flag in honor of his wife who lost her ...
(Date:10/3/2018)... ... October 03, 2018 , ... Babyscripts , the ... remotely monitor their pregnant patients’ progress and health, is now available to expectant ... network (MCW). Patients who choose to use Babyscripts will get tips and information ...
Breaking Medicine News(10 mins):
(Date:10/11/2018)... , ... October 11, 2018 , ... ... e-discovery software for corporate law departments and law firms, today announced it is ... should visit booth 110 to learn how corporate legal departments are using smart ...
(Date:10/7/2018)... ... October 07, 2018 , ... Dr. B. Aviva Preminger, elite plastic surgeon ... is an Ivy League-educated, Board Certified woman plastic surgeon specializing in cosmetic and reconstructive ... known for their exclusivity, and luxurious lifestyle publication is privileged to present Dr. Preminger ...
(Date:10/6/2018)... ... October 06, 2018 , ... ... 20 years. Number One On The List services improve search engine ranking - ... Conversion, Modernize Website, Press Releases, Marketing Programs, Email Newsletters, SEO, Packages of Services ...
Breaking Medicine Technology:
Cached News: